KA

Kunhippa Azhikunnath Mamu

Active Director Director DIN 10385841
DIN 10385841 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunhippa Azhikunnath Mamu

Data last updated:

Kunhippa Azhikunnath Mamu is a Director at Healitic Pharma Private Limited (since 2023). The company operates in Pharma.

DIN 10385841
Primary Designation Director
Industry Pharma
First Appointment 08 Nov 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healitic Pharma Private Limited U46497KA2023PTC180790
Director08 Nov 20232023Active

Board colleagues of Kunhippa Azhikunnath Mamu

NameDINCompanyDesignation
Azhikunnath Muhammed Shanoob10385842Healitic Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Healitic Pharma Private Limited
Premium access

Shareholding and investment profile for Kunhippa Azhikunnath Mamu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunhippa Azhikunnath Mamu

Kunhippa Azhikunnath Mamu currently holds 1 directorship: Healitic Pharma Private Limited (Director, since 08 Nov 2023).

Kunhippa Azhikunnath Mamu was first appointed on 08 Nov 2023 as Director at Healitic Pharma Private Limited.

The current boards of Kunhippa Azhikunnath Mamu's companies include Azhikunnath Muhammed Shanoob (Healitic Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available